spacer
home > epc > Spring 2008
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in the current issue of EPC.
   
Text
PDF
bullet
Marketplace & Business
When it comes to locating clinical trials, South Africa is often overlooked despite being a cost-effective location with a diverse, willing population. Catherine Lund at OnQ Consulting explains why more trials should come Out of Africa  
view
download pdf
Igor Stefanov at Synergy Research Group analyses how the clinical research market in Russia is showing significant year-on-year growth and is becoming a dominant global player – a sure-fire sign of a Russian Revolution  
view
download pdf
Rob Sexstone of 3di Information Solutions recommends that you Don’t Get Lost in Translation by ensuring that a product’s internationalisation and localisation needs are addressed as early on in the development cycle as possible  
view
download pdf
In A Master Class, Dr Nicholas Breakwell assesses the significant benefits to both employers and employees in studying for a Master of Science in Pharmaceutical Medicine; a course he believes not as widely-available to graduates as it should be  
view
download pdf
The increasingly competitive nature of the pharmaceutical sector is forcing employers to work even harder to recruit and retain the best candidates in order to remain at the top, claims Martin Blake of Volt Life Sciences in The Pharmaceutical Candidate  
view
download pdf
bullet
Legal & Regulatory
Once on the brink of a significant milestone, the Greek clinical trial industry has suffered in recent years due to the limitations imposed by red tape. Ana C Hernandez Daly and Vasiliki Poufti believe that The Clinical Trial Odyssey is finally reaching a favourable destination despite numerous setbacks  
view
download pdf
The continuous growth of the pharmaceutical industry is creating demand for statistical programmers, of which there is a severe shortage who specialise in clinical knowledge. In Practice Makes Perfect, Sunil Gupta and Mandyam Srirama at Quintiles offer advice on the importance of restructuring training programmes in order to take advantage of the abundance of available programmers from other industries  
view
download pdf
In Vigilant Competition, Annabelle Jerram at Wolters Kluwer discusses how the ever-increasing need for good pharmacovigilance practice is placing greater emphasis on the humble case report  
view
download pdf
bullet
Clinical Development
Properly-implemented adaptive designs are capable of improving all aspects of drug development. Olga Marchenko at i3 Statprobe assesses their importance for the entire clinical testing arena, in Trial and Error  
view
download pdf
Surrogate endpoints in drug development can be crucial when it comes to formulating more efficient clinical trial designs. In Surrogate Force, Tomasz Burzykowski at MSOURCE Medical Development considers the steps required to achieve this goal  
view
download pdf
Focus has recently been shifting to first-in-man and other early phase clinical studies; Keren Winmill at Penn Pharmaceutical Services Ltd analyses the quickest routes to Phase I, in On the Fast Track  
view
download pdf
Dr Graham Wylie of the Medical Research Network Ltd puts forward his strategies for more effective patient recruitment and retention in Western pharmaceutical markets, in On the Home Front  
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
The growth of the European oncology market is bringing with it added financial and regulatory concerns, though one can anticipate a bright future thanks to biotechnology-based targeted therapies, according to Paljit Sohal at Frost & Sullivan, in Optimal Oncology  
view
download pdf
In Cognitive Science, Andrew Blackwell of Cambridge Cognition talks to EPC about the significance of forward-looking specialised services and cognitive assessment products for achieving optimum treatment potential  
view
download pdf
The correct adoption of cognitive testing systems can significantly aid the clinical trial process. In Cerebral Intelligence, Mark Cusack at Cognitive Drug Research discusses the importance of clinically-relevant cognitive testing  
view
download pdf
bullet
LABS & Logistics
Geraint Thomas of Laminar Medica, in keeping with a key industry aim, searches for a cost-effective and safe transportation method for temperature-sensitive drugs, investigating the entire Protection Package and its implications for the pharma industry as a whole  
view
download pdf
In The Third Man, Angus G Cameron of Pharmarama assesses the strategic challenge of and the solutions available to procure specific comparator drugs for clinical trials, and the complications of managing such a procedure  
view
download pdf
bullet
DATA MANAGEMENT
Effective management of clinical trials is best undertaken At the Hub; investigator hub-sites employing electronic data capture are an optimal solution, purport Dr Hans-Detlev Stahl at Clinpharm International GmbH, and Maria Sumner and Rob Nichols at Phase Forward Europe Ltd  
view
download pdf
In Voicing Concerns, Claudia Horneck at Clinit AG assesses the use of interactive voice response systems in study settings, and the advantages they can present in terms of patient involvement and treatment allocation  
view
download pdf
bullet
ECG CORE LABS & CARDIAC SAFETY
Susan Boyle of Spacelabs Healthcare and Sasha Latypova of iCardiac Technologies, Inc, explore the potential of novel technologies in cardiac safety as a method to synchronise sensitive variables In a Heartbeat  
view
download pdf
Decreasing variability and optimising data quality is fundamental to the execution of thorough QT/QTc studies, argue Benoit Tyl, Bill Wheeler and Joy Olbertz at MDS Pharma Services in The Thorough QT Study  
view
download pdf
Improving cardiovascular safety in drug development is a continuous aim for the pharmaceutical industry in its entirety. Boaz Mendzelevski, a Cardiac Safety Consultant, examines the technologies available and methods involved in Safety First  
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Saneca Pharma strengthens senior team

Slovakia-based CDMO adds senior talent to its team to position the company for continued growth
More info >>

White Papers

Industrial Security in the Pharmaceutical Sector

COPA-DATA

As an attractive target for cyber attacks, pharmaceutical companies need to understand cyber security, assess weak points and implement the appropriate security measures. This white paper describes some of the most effective industrial security tools pharmaceutical companies have at their disposal in the era of Industry 4.0.
More info >>

Industry Events

BioTrinity 2018

23-25 April 2018, Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement